[CALT] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[CALT] Calliditas Therapeutics AB (publ)
Announcement Date
24-Apr-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- 89.09%
YoY- -398.99%
Quarter Report
CALT's Result
CALT's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 451,561 429,042 31,180 400 46,586 0 0 -
PBT -14,256 10,066 -218,467 -173,273 -22,973 -44,224 -40,544 -15.98%
Tax 4,112 13,747 199 175 77 441 -41 -
NP -18,368 -3,681 -219,170 -170,431 -23,050 -44,224 -40,544 -12.35%
Tax Rate - -136.57% - - - - - -
Total Cost 469,929 432,723 250,350 170,831 69,636 44,224 40,544 50.40%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -4.07 -0.86 -702.92 -42,607.75 -49.48 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.34 -0.07 -8.37 -6.83 -0.60 -1.26 -1.22 -19.17%
EPS Diluted -0.34 -0.07 -8.37 -6.83 -0.60 -1.26 -1.22 -19.17%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.